Delivery Order SPE2DE24D0013-SPE2D625F9S6U
- Not listed
- The Defense Logistics Agency's Medical Supply Chain division awarded a $5,440 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on May 6, 2025, with an ultimate completion date of May 13, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus detection. The award carries no set-aside designation and represents a continuation...
- The U.S. Defense Logistics Agency, through the Medical Supply Chain division, awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The delivery order addresses federal requirements for COVID-19, influenza, and respiratory syncytial virus...
- This delivery order, awarded on July 24, 2025, represents a $17,680 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain division and Cepheid Inc. for a COVID-19/Influenza/RSV diagnostic kit containing 10 viral tests. The contract is set to be completed by July 31, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This award is issued without a set-aside designation and falls under Cepheid's existing indefinite delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, on September 10, 2025. The delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, carries no set-aside designation. This award represents a procurement of diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and...
- The U.S. Defense Logistics Agency (under the Medical Supply Chain function) awarded a $6,800 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on August 18, 2025, with an ultimate completion date of August 25, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The award reflects Cepheid's specialized expertise in providing rapid molecular diagnostic testing for...
- The Defense Logistics Agency's Medical Supply Chain has awarded a $7,904 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, represents procurement of diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract was awarded on September 8, 2025, with an ultimate completion date of September 15, 2025, and carries no...
- The U.S. Defense Medical Supply Chain has awarded a $10,380 firm fixed-price delivery order to Cepheid Inc. for COVID-19/Influenza/Respiratory Syncytial Virus (RSV) diagnostic testing solutions. The contract, designated as delivery order 4568136312, was awarded on May 2, 2025, with an ultimate completion date of May 9, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This delivery order carries no set-aside designation and represents a continuation of the federal...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on May 19, 2025, with completion targeted for May 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious disease testing capabilities aligned with federal pandemic preparedness and ongoing surveillance needs. The order carries no set-aside designation and...
- The U.S. Defense Department's Medical Supply Chain division awarded a $23,475.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPCOV2/FLU/RSV-10, was awarded on July 29, 2025, with an ultimate completion date of August 12, 2025, and carries no set-aside designation. Work will be performed at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- The Defense Logistics Agency awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on June 6, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The order is scheduled for completion by June 13, 2025, with performance occurring at Cepheid's facility in Sunnyvale, California. This delivery order carries no set-aside designation and represents a discrete procurement under the company's existing contract vehicles with...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F9S6UDelivery Order
The Defense Logistics Agency's Medical Supply Chain branch awarded a $34,000 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic manufacturer based in Sunnyvale, California, for 10 tests of a COVID-19/Influenza/RSV diagnostic kit. The contract, issued on May 29, 2025, is scheduled for completion by June 6, 2025, with performance taking place in Sunnyvale. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing support to federal healthcare systems requiring rapid infectious disease diagnostics. This award likely stems from one of Cepheid's two significant Indefinite Delivery Vehicle contracts with the Veterans Administration, which provide the company's molecular diagnostic testing solutions across multiple federal healthcare networks. Cepheid specializes in GeneXpert diagnostic systems and related test kits for detecting infectious diseases, and this particular delivery order supports the federal government's ongoing need for multi-pathogen respiratory testing capabilities. The compressed timeline between award and completion dates suggests this represents an urgent procurement to fulfill immediate diagnostic testing requirements within the Defense Health enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 5/29/25 |